Abstract:Purpose: Aberrant hedgehog (Hh) signaling has been reported in various cancers including breast cancers and clinical trials targeting this pathway are currently ongoing. Preclinical evidence suggests that increased ligand-dependent Hh signaling in breast tumor epithelial (E) cells cross-talks and activates Hh pathway in the stroma (S) but the clinical implication of this E/S interaction is unknown. We sought to determine the expression of Hh proteins in the E and S compartments of primary breast tumor samples and correlate with clinical outcomes. Methods: Using tissue microarray (TMA) of ∼500 primary breast cancer samples (OSU 2009C009 A) that includes both primary breast tumor and axillary metastasis, the expression pattern of the key Hh signaling proteins (Shh, Gli-1, SMO, Ptch1) and a target gene of the pathway (BMI1) was determined by immunohistochemistry (IHC) in both the epithelial and stromal tissues and compared to other known prognostic/predictive markers such as age, stage, estrogen/progesterone receptor (ER/PR)/HER2 status and to disease-free survival (DFS). IHC was performed using Benchmark LT automated system from Ventana Medical Systems using previously published methods (Nuovo GJ, Nature protocols, 2009). Scoring was done by combining the intensity and percentage of cells staining with respective antibodies by three independent measurements. Results: Analysis of a total of 315 primary breast tumors revealed the following percentage of tumors with high expression of Hh proteins in the E/S compartments respectively: Shh (72/31%), Gli-1 (69/53%), SMO (40/64%), and Ptch-1 (93/74%). Analyzing the interaction between the epithelial and stromal expressions of these proteins, we found positive correlation between i) high Shh and SMO in the epithelial cells and Gli-1 in the stroma, and ii) high Gli-1 in the epithelial cells and target protein Bmi1 in the stroma. High intensity staining of Gli-1 in the tumor epithelial cells was significantly associated with higher stage, grade, ER negative status and worse DFS. Adjusting for stage and ER status, tumors with increased epithelial Gli-1 expression was still significantly associated with worse DFS (p=0.0131, survival analysis) when compared to tumors with low expression. In particular, among the ER negative and node positive patients higher Gli-1 expression in epithelial cells was very significantly associated with poor DFS (p= Conclusions: We report here for the first time a positive correlation between expression of Hh proteins in the stromal and epithelial compartment of primary breast tumors. Furthermore, we observed that higher Gli-1 expression in the tumor epithelial cells was associated with worse DFS, particularly in the ER negative, node-positive tumors suggesting that aberrant Hh signaling may contribute to drug-resistance and hence a rationale therapeutic target. Further correlative studies between clinical parameters and additional Hh target genes in these tumors are in progress. Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr S6-9.

Cooperatively Transcriptional and Epigenetic Regulation of Sonic Hedgehog Overexpression Drives Malignant Potential of Breast Cancer.

Expression and Regulation Mechanisms of Sonic Hedgehog in Breast Cancer

An Epigenetic Switch Induced by Shh Signalling Regulates Gene Activation During Development and Medulloblastoma Growth

HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Targeting of Sonic Hedgehog-Gli Signaling: A Potential Therapeutic Target for Patients with Breast Cancer

Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation

A Critical Role of Sonic Hedgehog Signaling in Maintaining the Tumorigenicity of Neuroblastoma Cells

Hedgehog Pathway Orchestrates the Interplay of Histone Modifications and Tailors Combination Epigenetic Therapies in Breast Cancer

Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments

Expression Of Hedgehog Proteins In The Epithelial And Stromal Compartments Of Primary Breast Tumors And Its Prognostic Significance

Epigenetic Silencing of Sonic Hedgehog Elicits Antitumor Immune Response and Suppresses Tumor Growth by Inhibiting the Hedgehog Signaling Pathway in Metastatic Spine Tumors in Sprague-Dawley Rats

Sonic Hedgehog Signaling in Thyroid Cancer

Expression of Sonic Hedgehog (SHH) in human lung cancer and the impact of YangZheng XiaoJi on SHH-mediated biological function of lung cancer cells and tumor growth.

Unravelling the Mysteries of the Sonic Hedgehog Pathway in Cancer Stem Cells: Activity, Crosstalk and Regulation

Shon, A Novel Secreted Protein, Regulates Epithelial-Mesenchymal Transition Through Transforming Growth Factor-Beta Signaling In Human Breast Cancer Cells

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Autocrine Sonic Hedgehog Signaling Promotes Gastric Cancer Proliferation Through Induction Of Phospholipase C Gamma 1 And The Erk1/2 Pathway

Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions

TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling

Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway